|
WO2020109508A1
|
|
Sampling device for sampling from a surface of an industrial vessel without requiring a person to descend into an industrial vessel, using a swab
|
|
WO2020099571A1
|
|
Method of preserving cells for therapeutic use
|
|
FR3101640A1
|
|
Human monocyte cell line and its use as a cell model of phagocytosis.
|
|
WO2020053661A1
|
|
Methods of purifying antibodies from the milk of transgenic non-human mammals comprising the use of chitosan
|
|
FR3090321A1
|
|
Fibrinogen filtration process
|
|
WO2019116096A1
|
|
Production of fc fragments
|
|
EP3716762A1
|
|
Method for the cryopreservation of cells for therapeutic purposes
|
|
FR3082729A1
|
|
CONDITIONS OF STORAGE OF A PROTEIN COMPOSITION COMPRISING SURFACTANT AND DEVELOPMENT OF SURFACTANT CONTENT
|
|
FR3082427A1
|
|
COMBINATION OF FACTOR VII AND A BISPECIFIC ANTIBODY ANTI-FACTORS IX AND X
|
|
EP3581203A1
|
|
Antibodies with increased activity in the digestive tract
|
|
FR3081328A1
|
|
COMPOSITION OF CONCENTRATED HUMAN IMMUNOGLOBULINS
|
|
FR3080376A1
|
|
HIGHLY SIALYLATED AUTOANTICORPS AND USES THEREOF
|
|
WO2018178594A1
|
|
Prevention of an infection by the respiratory syncytial virus in the upper respiratory tract
|
|
WO2018178593A1
|
|
Composition of immunoglobulins of use for treating viral infections
|
|
WO2018178601A1
|
|
Treatment of an infection by the respiratory syncytial virus
|
|
FR3077296A1
|
|
Dimers of factor x variants
|
|
FR3076294A1
|
|
PROCESS FOR PURIFYING ANTIBODIES FROM RAW MILK
|
|
FR3075603A1
|
|
Pharmaceutical composition for oral administration of antibodies for the treatment of gastrointestinal tract diseases
|
|
WO2018109213A1
|
|
Aptamers directed against a kappa light chain-containing protein and uses thereof
|
|
WO2018109209A1
|
|
Combination of anti-cd303 and anti-amhrii antibodies
|
